title: Receptor-targeted anticancer therapy.
authors.affiliation: Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. ben.seon@roswellpark.org
authors.forename: Ben K
authors.initials: BK
authors.lastname: Seon
authors.forename: Yuro
authors.initials: Y
authors.lastname: Haruta
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Matsuno
authors.forename: Akinao
authors.initials: A
authors.lastname: Haba
authors.forename: Norihiko
authors.initials: N
authors.lastname: Takahashi
authors.forename: Xinwei
authors.initials: X
authors.lastname: She
authors.forename: Naoko
authors.initials: N
authors.lastname: Harada
authors.forename: Shima
authors.initials: S
authors.lastname: Uneda
authors.forename: Masanori
authors.initials: M
authors.lastname: Tsujie
authors.forename: Tomoko
authors.initials: T
authors.lastname: Tsujie
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Toi
authors.forename: Hilda
authors.initials: H
authors.lastname: Tsai
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology; D051925:CD79 Antigens / Q000037:antagonists & inhibitors* / Q000276:immunology; D000071063:Endoglin; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D051925:CD79 Antigens; C064206:ENG protein, human; D000071063:Endoglin; D011956:Receptors, Cell Surface